A multicenter randomized trial across Europe has shown that Olympus’ cloud-based AI detection system, CADDIE™, significantly improves the detection of clinically important colorectal lesions—particularly large adenomas, flat lesions, and sessile serrated lesions, which are often missed in routine colonoscopy.
The EAGLE trial, involving more than 800 patients, reported a 7.3% increase in adenoma detection rate and substantial gains in identifying hard-to-detect lesions, without disrupting workflow or increasing unnecessary resections.
Beyond detection gains, the study highlights a broader shift: AI delivered through the cloud may remove hardware barriers, enable faster deployment, and open the door to scalable, continuously improving endoscopy platforms.
For gastroenterologists, the findings signal that AI is moving from experimental tools to infrastructure—embedded directly into everyday endoscopy practice.